Glenmark Pharma gets final approval for Clobetasol Propionate Foam
Glenmark Pharma gets final approval for Clobetasol Propionate Foam

Glenmark Pharma gets final approval for Clobetasol Propionate Foam

Nidhi Jani Article rating: 2.5

Glenmark Pharmaceuticals announces that it has received final USFDA approval for Clobetasol Propionate Foam. The market for the medicine was approximately US$50.9 million in the 12-month period ending December 2018 in the US market, according to pharma market tracker IQVIA.


Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 3.3

Overall volumes in futures & options currently stand at 1.17 crore contracts with a turnover of Rs. 7,39,087.25 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.17 crore contracts with a turnover of Rs. 7,39,087.25 crore.

PNC Infratech bags project worth Rs. 186 crore from PWD
PNC Infratech bags project worth Rs. 186 crore from PWD

PNC Infratech bags project worth Rs. 186 crore from PWD

Shohini Nath Article rating: 3.2

PNC Infratech has been awarded a project worth Rs. 186 crore on Friday. The shares of the company opened in green as the company received the Letter of Award (LoA) from Public Works Department (PWD), Uttar Pradesh.

Index trend and stocks in action February 18, 2019
Index trend and stocks in action February 18, 2019

Index trend and stocks in action February 18, 2019

Karan Dsij Article rating: 5.0

Going ahead, a positive follow-through above the Friday’s session high of 10,786 can lead to pull-back towards the level of 10,860 as the important 200-day moving average is placed at this level. On the flip side, the zone of 10,620-10,580 would be the key area to watch out for. Stocks in news: Signet Industries, Dr Reddy’s Laboratories, Tech Mahindra, NBCC, Coffee Day Enterprises, TRF and Wipro.

After the hammering last week, indices hope for a recovery
After the hammering last week, indices hope for a recovery

After the hammering last week, indices hope for a recovery

Karan Dsij Article rating: 5.0

The set-up for the Indian stock markets to begin the week is perfect as cues from the global peers are cheerful and bulls cannot hope for a better pitch than today to come out and take on the bears with their horns after the hammering they received last week. The outlook for the day is a flat start at the time of writing, SGX Nifty is trading around 10,799, up by 24 points. 

Stocks approaching Ex-date this week
Stocks approaching Ex-date this week

Stocks approaching Ex-date this week

Gayathri Udyawar Article rating: 5.0

For an avid investor, earnings are what semester exams are for students. Investors are keen to know how the companies that they hold fared during the quarter and whether they have any goodies to offer. Read on to know which stocks will be approaching their ex-date for bonuses and dividends during the week.

Stocks that attracted mutual fund managers in January 2019
Stocks that attracted mutual fund managers in January 2019

Stocks that attracted mutual fund managers in January 2019

Henil Shah Article rating: 5.0

Many of you are interested in knowing what fund managers are buying and selling. So, let’s find out which stocks attracted the fund managers in the month of January 2019.

RSS
First26832684268526862688269026912692Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR